A股異動 | 威華股份(002240.SZ)漲超4% 擬12億元投建氫氧化鋰項目
格隆匯10月23日丨威華股份(002240.SZ)現報12.54元,漲4.59%,暫成交7858萬元,最新總市值93億元。威華股份昨晚公佈,公司擬通過全資子公司遂寧盛新鋰業有限公司在射洪市投資建設年產3萬噸氫氧化鋰項目,該項目總投資額為12億元,其中首期建設年產2萬噸氫氧化鋰項目於年內開工建設,首期建設投資額為8.5億元。該項目實施後,將擴大公司氫氧化鋰的整體產能和產量。有助於公司拓展下游客户,與優質客户建立長期戰略合作關係,做大做強鋰鹽產業,進一步拓展和提升公司鋰電新能源材料業務規模,符合公司戰略規劃和經營發展需要。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.